Rosacea Medical Management Guidelines
June 2008 | Volume 7 | Issue 6 | Original Article | 531 | Copyright © June 2008
James Q. Del Rosso DO, Hilary Baldwin MD, Guy Webster MD
AbstractObjectives:The objectives of these Guidelines are to provide an overview of the fundamental disease state of rosacea and quality of life implications and outline available pharmacological treatments for rosacea with reference to supporting research and literature. The pharmacological agents discussed are inclusive of those that are FDA-approved based on phase 3 pivotal trials, commonly used agents based on extensive clinical experience, and less commonly used alternatives reported in peerreviewed literature.